Arnatar - About the company
Arnatar is a series A company based in San Diego (United States), founded in 2021. It operates as a Developer of RNA therapeutics to treat rare diseases. Arnatar has raised $50M in funding from Apricot Capital. The company has 279 active competitors, including 78 funded and 97 that have exited. Its top competitors include companies like BridgeBio, Alnylam and PTC Therapeutics.
Company Details
Developer of RNA therapeutics to treat rare diseases. The company specializes in the development of novel nucleic acid medications using RNA targeting antisense technologies to treat diseases in both liver and extra-hepatic organs and for both common and rare disease indications.
- Website
- www.arnatar.com/
- Email ID
- *****@arnatar.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2021
Location
San Diego, United States
Stage
Series A
Total Funding
$50M in 2 rounds
Latest Funding Round
Investors
Ranked
123rd among 279 active competitors
Sign up to download Arnatar's company profile
Arnatar's funding and investors
Arnatar has raised a total funding of $50M over 2 rounds. Its first funding round was on Sep 19, 2022. Its latest funding round was a Series A round on Apr 08, 2024 for $*****. 11 investors participated in its latest round. Arnatar has 12 institutional investors.
Here is the list of recent funding rounds of Arnatar:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 08, 2024 | 3907196 | Series A | 9600523 | 8749663 | 5046571 | 7619976 |
Sep 19, 2022 | 4860479 | Seed | 6101974 | 7179074 | 7182557 |
Access funding benchmarks and valuations. Sign up today!View details of Arnatar's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Arnatar's Competitors and alternates
Top competitors of Arnatar include BridgeBio, Alnylam and PTC Therapeutics. Here is the list of Top 10 competitors of Arnatar, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  BridgeBio 2015, Palo Alto (United States), Public | Developer of therapeutics for the treatment of genetic diseases | $434M | 81/100 | |
2nd | Alnylam 2002, Cambridge (United States), Public | Developer of RNA interference-based therapeutics for multiple disorders | $17M | 79/100 | |
3rd | PTC Therapeutics 1998, South Plainfield (United States), Public | Developer of small molecule drugs for the treatment of rare diseases | $248M | 77/100 | |
4th | Alexion 1992, Zurich (Switzerland), Acquired | Developer of therapies for patients with devastating and rare diseases | $133M | 74/100 | |
5th | Spark Therapeutics 2013, Philadelphia (United States), Acquired | Developer of gene therapy for rare diseases | $82.8M | 73/100 | |
6th | Blueprint Medicines 2008, Cambridge (United States), Acquired | Developer of selective kinase inhibitors for patients with genomically defined cancers | $115M | 71/100 | |
7th | Bluebird Bio 1992, Cambridge (United States), Acquired | Developer of gene therapies for severe genetic and rare diseases | $136M | 71/100 | |
8th | Agios Pharmaceuticals 2008, Cambridge (United States), Public | Developer of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism | $120M | 70/100 | |
9th | Rhythm Pharmaceuticals 2010, Boston (United States), Public | Developer of peptide therapeutics for the treatment of rare genetic deficiencies | $84M | 70/100 | |
10th |  Generation Bio 2016, Cambridge (United States), Acquired | Developer of gene therapies for rare liver and eye diseases | $236M | 69/100 | |
123rd |  Arnatar 2021, San Diego (United States), Series A | Developer of RNA therapeutics to treat rare diseases | $50M | 40/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Arnatar's competitors? Click here to see the top ones
Arnatar's Investments and acquisitions
Arnatar has made no investments or acquisitions yet.
Reports related to Arnatar
Here is the latest report on Arnatar's sector:
Are you a Founder ?
FAQs about Arnatar
Explore our recently published companies
